foxo4 dri senolytic human trial FOXO4-DRI Results: What to Expect (2026) FOXO4-DRI - Averix Labs
FOXO4 DRI Averix Labs FOXO4 DRI regulates endothelial cell senescence via the P53 signaling pathway PMC Buy FOXO4 DRI Exceptional 99%+ Purity Third Party COA Included The costs and benefits of senotherapeutics for human health The Lancet Healthy Longevity Peptide Inhibitors Targeting FOXO4 p53 Interactions and Inducing Senescent Cancer Cell specific Apoptosis Journal of Medicinal Chemistry
Pay in 4 interest-free payments of $5.58 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6



00300-7/asset/fc51add5-22b1-4645-9507-e89d0738c67a/main.assets/gr1_lrg.jpg)
